NASDAQ:MLAB

Mesa Laboratories - MLAB Stock Forecast, Price & News

$144.02

+3.19 (+2.27%)

(As of 10/3/2022 12:00 AM ET)

Add

Compare

Today's Range: $138.77
▼
$149.98
50-Day Range: $139.58
▼
$214.98
52-Week Range: $136.11
▼
$333.42

Volume: 53,305 shs
Average Volume: 38,174 shs
Market Capitalization: $765.75 million

P/E Ratio: N/A
Dividend Yield: 0.45%
Price Target: N/A

Mesa Laboratories MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
6.65% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: 1.42
Based on 5 Articles This Week
Insider Trading: Selling Shares
$724,075 Sold Last Quarter
Proj. Earnings Growth: 5.70%
From $5.26 to $5.56 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.77 out of 5 stars

Medical Sector

937th out of 1,093 stocks

Process Control Instruments Industry

11th out of 12 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Mesa Laboratories.

3.0

Short Interest

Percentage of Shares Shorted
6.65% of the float of Mesa Laboratories has been sold short.
Short Interest Ratio / Days to Cover
Mesa Laboratories has a short interest ratio ("days to cover") of 6.4.
Change versus previous month
Short interest in Mesa Laboratories has recently decreased by 10.07%, indicating that investor sentiment is improving significantly.

0.8

Dividend Strength

Dividend Yield
Mesa Laboratories has a dividend yield of 0.45%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Mesa Laboratories does not have a long track record of dividend growth.
Dividend Sustainability
Based on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 11.51% next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for MLAB.

3.0

News and Social Media Coverage

News Sentiment
Mesa Laboratories has a news sentiment score of 1.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.84 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Mesa Laboratories this week, compared to 0 articles on an average week.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Mesa Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $724,075.00 in company stock.
Percentage Held by Insiders
Only 5.50% of the stock of Mesa Laboratories is held by insiders.
Percentage Held by Institutions
92.70% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Mesa Laboratories are expected to grow by 5.70% in the coming year, from $5.26 to $5.56 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Mesa Laboratories is -480.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Mesa Laboratories is -480.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Mesa Laboratories has a P/B Ratio of 1.92. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Mesa Laboratories (NASDAQ:MLAB) Stock

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

MLAB Stock News Headlines

September 29, 2022 | americanbankingnews.com

Mesa Laboratories (NASDAQ:MLAB) Stock Price Down 2.4%

September 11, 2022 | finance.yahoo.com

Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 39% Below Their Intrinsic Value Estimate

September 9, 2022 | seekingalpha.com

Mesa Laboratories: Softening Bottom Line Fundamentals, Fairly Priced

August 6, 2022 | seekingalpha.com

Mesa Laboratories, Inc. 2023 Q1 - Results - Earnings Call Presentation

August 4, 2022 | finance.yahoo.com

Mesa Labs (MLAB) Q1 Earnings and Revenues Miss Estimates

July 28, 2022 | finance.yahoo.com

Mesa Labs (MLAB) to Report Q1 Results: Wall Street Expects Earnings Growth

July 7, 2022 | marketwatch.com

Mesa Laboratories stock price target cut to $240 from $295 at J.P. Morgan

June 27, 2022 | finance.yahoo.com

Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

May 31, 2022 | nasdaq.com

Mesa Labs (MLAB) Surpasses Q4 Earnings and Revenue Estimates

May 26, 2022 | seekingalpha.com

Mesa Laboratories goes ex-dividend tomorrow

May 13, 2022 | finance.yahoo.com

The five-year decline in earnings for Mesa Laboratories NASDAQ:MLAB) isn't encouraging, but shareholders are still up 55% over that period

April 26, 2022 | nasdaq.com

Mesa Laboratories is Now Oversold (MLAB)

April 12, 2022 | finance.yahoo.com

News Flash: Analysts Just Made A Captivating Upgrade To Their Mesa Laboratories, Inc. (NASDAQ:MLAB) Forecasts

April 4, 2022 | finance.yahoo.com

Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 21% Above Their Intrinsic Value Estimate

March 30, 2022 | nasdaq.com

Analysts See 20% Upside For SPSM

February 3, 2022 | finance.yahoo.com

Mesa Labs Announces Third Quarter Results

February 3, 2022 | finance.yahoo.com

Are Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Mixed Financials Driving The Negative Sentiment?

February 3, 2022 | finance.yahoo.com

Mesa Labs (MLAB) Q3 Earnings Miss Estimates

February 3, 2022 | benzinga.com

Mesa Laboratories: Q3 Earnings Insights

December 26, 2021 | nasdaq.com

Mesa Laboratories, Inc. Shares Near 52-Week High - Market Mover

December 23, 2021 | nasdaq.com

Mesa Laboratories, Inc. Shares Close in on 52-Week High - Market Mover

December 20, 2021 | finance.yahoo.com

What History Shows Us About 2022 Market Returns

December 20, 2021 | finance.yahoo.com

Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?

December 11, 2021 | finance.yahoo.com

Mesa Laboratories Inc (MLAB) CFO John Sakys Sold $570,893 of Shares

November 8, 2021 | benzinga.com

How Good Are Mesa Laboratories's Earnings? | Return On Invested Capital

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

MLAB Company Calendar

Last Earnings: 8/04/2022
Ex-Dividend for 9/15 Dividend: 8/30/2022
Dividend Payable: 9/15/2022
Today: 10/03/2022
Next Earnings (Estimated): 11/03/2022
Fiscal Year End: 3/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Process control instruments
Sub-Industry: Electronic Equipment & Instruments
Sector: Medical
Current Symbol: NASDAQ:MLAB
CUSIP: 59064R10
CIK: 724004
Web: www.mesalabs.com
Phone: (303) 987-8000
Fax: 303-987-8989
Employees: 506
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.30)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 27.38
P/E Growth: N/A
Net Income: $1.87 million
Net Margins: -0.78%
Pretax Margin: -1.63%
Return on Equity: 5.80%
Return on Assets: 3.34%

Debt

Debt-to-Equity Ratio: 0.57
Current Ratio: 2.90
Quick Ratio: 2.29

Sales & Book Value

Annual Sales: $184.34 million
Price / Sales: 4.15
Cash Flow: $11.51 per share
Price / Cash Flow: 12.51
Book Value: $75.07 per share
Price / Book: 1.92

Miscellaneous

Outstanding Shares: 5,317,000
Free Float: 5,025,000
Market Cap: $765.75 million
Optionable: Not Optionable
Beta: 0.65

Key Executives

Mr. Gary M. Owens (Age 54)
CEO, Pres & Director
Comp: $1.66M

Mr. John V. Sakys (Age 53)
VP, CFO & Chief Accounting Officer
Comp: $759.57k

Mr. Brian David Archbold (Age 46)
Sr. VP of Continuous Improvement
Comp: $509.89k

Ms. Gina Hinman Trulli
VP of HR

Mr. Bryan T. Leo
Sr. VP of Operations

Mr. Garrett Krushefski
Sr. VP of Operations

Mr. Peter M. Dansky (Age 61)
Pres of Clinical Genomics

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

MLAB Stock - Frequently Asked Questions

How have MLAB shares performed in 2022?: Mesa Laboratories' stock was trading at $328.09 on January 1st, 2022. Since then, MLAB stock has decreased by 55.8% and is now trading at $145.02.
View the best growth stocks for 2022 here.
When is Mesa Laboratories' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our MLAB earnings forecast.
How were Mesa Laboratories' earnings last quarter?: Mesa Laboratories, Inc. (NASDAQ:MLAB) released its earnings results on Thursday, August, 4th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by $1.05. The medical instruments supplier had revenue of $50.45 million for the quarter, compared to analyst estimates of $52.63 million. Mesa Laboratories had a negative net margin of 0.78% and a positive trailing twelve-month return on equity of 5.80%.
How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?: Mesa Laboratories declared a quarterly dividend on Wednesday, July 6th. Stockholders of record on Wednesday, August 31st will be paid a dividend of $0.16 per share on Thursday, September 15th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.44%. The ex-dividend date is Tuesday, August 30th.
Read our dividend analysis for MLAB.
Is Mesa Laboratories a good dividend stock?: Mesa Laboratories (NASDAQ:MLAB) pays an annual dividend of $0.64 per share and currently has a dividend yield of 0.45%.
Read our dividend analysis for MLAB.
What is Gary Owens' approval rating as Mesa Laboratories' CEO?: 5 employees have rated Mesa Laboratories Chief Executive Officer Gary Owens on Glassdoor.com. Gary Owens has an approval rating of 51% among the company's employees. This puts Gary Owens in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Mesa Laboratories own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA), Altria Group (MO), Micron Technology (MU), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD) and Becton, Dickinson and (BDX).
What is Mesa Laboratories' stock symbol?: Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."
How do I buy shares of Mesa Laboratories?: Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Mesa Laboratories' stock price today?: One share of MLAB stock can currently be purchased for approximately $145.02.
How much money does Mesa Laboratories make?: Mesa Laboratories (NASDAQ:MLAB) has a market capitalization of $771.07 million and generates $184.34 million in revenue each year. The medical instruments supplier earns $1.87 million in net income (profit) each year or ($0.30) on an earnings per share basis.
How many employees does Mesa Laboratories have?: The company employs 506 workers across the globe.
How can I contact Mesa Laboratories?: Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The official website for the company is www.mesalabs.com. The medical instruments supplier can be reached via phone at (303) 987-8000, via email at investorrelations@mesalabs.com, or via fax at 303-987-8989.

This page (NASDAQ:MLAB) was last updated on 10/3/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Mesa Laboratories - MLAB Stock Forecast, Price & News

Mesa Laboratories MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Company Ownership

Earnings and Valuation

About Mesa Laboratories (NASDAQ:MLAB) Stock

MLAB Stock News Headlines

MLAB Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

MLAB Stock - Frequently Asked Questions

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™